Delivery Order SPE2DR25D3016-SPE2DR26FG3QV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $31,740.85 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count packages). This competitively awarded, firm fixed-price delivery order was issued on January 9, 2026, with an ultimate completion date of January 12, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside contract, this award reflects open competition in the...
- The Defense Logistics Agency awarded a $18,664.07 delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 4 mg tablets (30-count units) with a completion date of September 11, 2025. This competitive award, issued as a firm fixed-price delivery order with no set-aside designation, represents a single transaction under AmerisourceBergen's larger contract vehicle with the agency. The pharmaceutical product will be delivered to the company's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $21,526.80 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This firm fixed-price delivery order, awarded on January 13, 2026, with an ultimate completion date of January 14, 2026, represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a $3,117.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packaging) with a completion date of September 24, 2025. This is a non-set-aside competitive award issued to AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania, where the company is headquartered. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,619.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on January 22, 2026, with completion expected by January 23, 2026. This is a non-set-aside, competitively awarded contract with performance in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,259.48 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count package) on January 21, 2026, with ultimate completion by January 22, 2026. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $12,886.87 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on January 16, 2026, with completion targeted for January 20, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a $1,151.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply) on January 13, 2026, with an ultimate completion date of January 14, 2026. This contract was awarded without a set-aside designation on a competitive basis and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $12,033.07 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 22, 2025. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $15,452.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Ondansetron ODT 8 mg tablets (30-count units), with an ultimate completion date of January 8, 2026. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG3QVDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $23,087.13 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on January 21, 2026, with completion expected by January 22, 2026. This contract was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the parent organization Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. Ondansetron is an anti-nausea medication commonly used in military and veterans' healthcare settings to manage chemotherapy-induced nausea, post-operative nausea, and other clinical conditions. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains extensive portfolio capabilities across multiple therapeutic domains, enabling efficient fulfillment of government pharmaceutical requirements through its established infrastructure with DLA. The competitively awarded nature of this transaction and the firm fixed-price structure reflect standard procurement practices within the Defense Logistics Agency's pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.1k | 1/20/26 |